• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前肾上腺髓质素在社区获得性肺炎儿童管理中的应用:一项初步前瞻性观察研究。

Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study.

作者信息

Sardà Sánchez Marta, Hernández Joan Calzada, Hernández-Bou Susanna, Teruel Gemma Claret, Rodríguez Jesús Velasco, Cubells Carles Luaces

机构信息

Emergency Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Passeig Sant Joan de Déu 2, Esplugues de Llobregat, Barcelona, Spain.

出版信息

BMC Res Notes. 2012 Jul 20;5:363. doi: 10.1186/1756-0500-5-363.

DOI:10.1186/1756-0500-5-363
PMID:22818355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431981/
Abstract

BACKGROUND

In adult population with community acquired pneumonia high levels of pro-adrenomedullin (pro-ADM) have been shown to be predictors of worse prognosis. The role of this biomarker in pediatric patients had not been analyzed to date. The objective of this study is to know the levels of pro-ADM in children with community acquired pneumonia (CAP) and analyze the relation between these levels and the patients' prognosis.

FINDINGS

Prospective observational study including patients attended in the emergency service (January to October 2009) admitted to hospital with CAP and no complications at admission. The values for pro-ADM were analyzed in relation to: need for oxygen therapy, duration of oxygen therapy, fever and antibiotic therapy, complications, admission to the intensive care unit, and length of hospital stay. Fifty patients were included. Ten presented complications (7 pleural effusion). The median level of pro-ADM was 1.0065 nmol/L (range 0.3715 to 7.2840 nmol/L). The patients presenting complications had higher levels of pro-ADM (2.3190 vs. 1.1758 nmol/L, p = 0.013). Specifically, the presence of pleural effusion was associated with higher levels of pro-ADM (2.9440 vs. 1.1373 nmol/L, p < 0.001).

CONCLUSIONS

In our sample of patients admitted to hospital with CAP, pro-ADM levels are related to the development of complications during hospitalization.

摘要

背景

在社区获得性肺炎的成年人群中,高水平的前肾上腺髓质素(pro-ADM)已被证明是预后较差的预测指标。迄今为止,这种生物标志物在儿科患者中的作用尚未得到分析。本研究的目的是了解社区获得性肺炎(CAP)患儿的pro-ADM水平,并分析这些水平与患者预后之间的关系。

研究结果

前瞻性观察性研究,纳入2009年1月至10月在急诊就诊并因CAP入院且入院时无并发症的患者。分析了pro-ADM值与以下因素的关系:氧疗需求、氧疗持续时间、发热和抗生素治疗、并发症、入住重症监护病房以及住院时间。共纳入50例患者。10例出现并发症(7例胸腔积液)。pro-ADM的中位数水平为1.0065 nmol/L(范围0.3715至7.2840 nmol/L)。出现并发症的患者pro-ADM水平较高(2.3190对1.1758 nmol/L,p = 0.013)。具体而言,胸腔积液的存在与较高的pro-ADM水平相关(2.9440对1.1373 nmol/L,p < 0.001)。

结论

在我们因CAP入院的患者样本中,pro-ADM水平与住院期间并发症的发生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/3431981/062e79739715/1756-0500-5-363-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/3431981/062e79739715/1756-0500-5-363-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d490/3431981/062e79739715/1756-0500-5-363-1.jpg

相似文献

1
Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study.前肾上腺髓质素在社区获得性肺炎儿童管理中的应用:一项初步前瞻性观察研究。
BMC Res Notes. 2012 Jul 20;5:363. doi: 10.1186/1756-0500-5-363.
2
Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.降肾上腺髓质素原对社区获得性肺炎不良结局的识别性能。
J Infect. 2015 May;70(5):457-66. doi: 10.1016/j.jinf.2014.12.003. Epub 2014 Dec 11.
3
Reliability of Pro-adrenomedullin and Interleukin 1β in Predicting Severity of Community-Acquired Pneumonia in Pediatric Patients.前肾上腺髓质素和白细胞介素1β在预测儿童社区获得性肺炎严重程度中的可靠性
Ann Clin Lab Sci. 2018 Jan;48(1):81-89.
4
Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.与临床严重程度评分PSI和CURB相比,急诊科社区获得性肺炎患者中MR-pro-肾上腺髓质素的预后性能。
PLoS One. 2017 Nov 21;12(11):e0187702. doi: 10.1371/journal.pone.0187702. eCollection 2017.
5
Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study.前肾上腺髓质素和 copeptin 在小儿肺炎中的应用:一项前瞻性诊断准确性研究。
BMC Infect Dis. 2015 Aug 19;15:347. doi: 10.1186/s12879-015-1095-5.
6
Multidimensional Prognostic Index and pro-adrenomedullin plasma levels as mortality risk predictors in older patients hospitalized with community-acquired pneumonia: a prospective study.多维度预后指数和前肾上腺髓质素血浆水平作为老年社区获得性肺炎住院患者死亡风险的预测指标:一项前瞻性研究。
Panminerva Med. 2018 Sep;60(3):80-85. doi: 10.23736/S0031-0808.18.03408-0. Epub 2018 Mar 15.
7
Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.降钙素原在社区获得性肺炎所致严重脓毒症和脓毒性休克患者中的预后价值。
Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542. eCollection 2012.
8
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].前肾上腺髓质素用于预测社区获得性肺炎的严重程度和预后[国际标准随机对照试验编号:ISRCTN04176397]
Crit Care. 2006;10(3):R96. doi: 10.1186/cc4955. Epub 2006 Jun 28.
9
Biomarkers and community-acquired pneumonia: tailoring management with biological data.生物标志物与社区获得性肺炎:利用生物学数据调整管理策略。
Semin Respir Crit Care Med. 2012 Jun;33(3):266-71. doi: 10.1055/s-0032-1315638. Epub 2012 Jun 20.
10
Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.原肾上腺素能预处理改善 ICU 早期入住风险评分对预测社区获得性早期重症肺炎的价值。
Chest. 2012 Dec;142(6):1447-1454. doi: 10.1378/chest.11-2574.

引用本文的文献

1
Mid-Regional Proadrenomedullin Levels in Primary Immunodeficiencies Complicated with Pulmonary Manifestations.原发性免疫缺陷合并肺部表现患者的中段肾上腺髓质素水平
Indian J Clin Biochem. 2023 Oct;38(4):475-484. doi: 10.1007/s12291-022-01061-9. Epub 2022 Sep 9.
2
A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker.儿科患者中肾上腺髓质素的综述:一种有用的生物标志物。
Children (Basel). 2022 Aug 6;9(8):1181. doi: 10.3390/children9081181.
3
The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections.

本文引用的文献

1
Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.降钙素原在社区获得性肺炎所致严重脓毒症和脓毒性休克患者中的预后价值。
Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542. eCollection 2012.
2
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.降钙素原对社区获得性肺炎的预后预测价值与其病因无关。
Eur Respir J. 2012 May;39(5):1144-55. doi: 10.1183/09031936.00080411. Epub 2011 Nov 10.
3
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.
copeptin 和 mid regional proadrenomedullin(MR-proADM)在儿科下呼吸道感染中的动力学特征。
PLoS One. 2022 Mar 10;17(3):e0264305. doi: 10.1371/journal.pone.0264305. eCollection 2022.
4
Proadrenomedullin Predicts Severe Disease in Children With Suspected Community-acquired Pneumonia.原胆素原预测疑似社区获得性肺炎患儿的严重疾病。
Clin Infect Dis. 2021 Aug 2;73(3):e524-e530. doi: 10.1093/cid/ciaa1138.
5
Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study.体外循环后生物标志物对儿科的预后价值:前瞻性 PANCAP 研究。
PLoS One. 2019 Jun 17;14(6):e0215690. doi: 10.1371/journal.pone.0215690. eCollection 2019.
6
Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?儿童社区获得性肺炎的预后评分和生物标志物:我们进展到了什么程度?
Pediatric Health Med Ther. 2017 Feb 20;8:9-18. doi: 10.2147/PHMT.S126001. eCollection 2017.
7
Predictive value of copeptin as a severity marker of community-acquired pneumonia.copeptin作为社区获得性肺炎严重程度标志物的预测价值
Electron Physician. 2017 Jul 25;9(7):4880-4885. doi: 10.19082/4880. eCollection 2017 Jul.
8
Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study.前肾上腺髓质素和 copeptin 在小儿肺炎中的应用:一项前瞻性诊断准确性研究。
BMC Infect Dis. 2015 Aug 19;15:347. doi: 10.1186/s12879-015-1095-5.
9
Biomarkers for community-acquired pneumonia in the emergency department.急诊科社区获得性肺炎的生物标志物
Curr Infect Dis Rep. 2014 Dec;16(12):451. doi: 10.1007/s11908-014-0451-8.
10
New markers in pneumonia.肺炎新标志物。
Clin Chim Acta. 2013 Apr 18;419:19-25. doi: 10.1016/j.cca.2013.01.011. Epub 2013 Feb 4.
降钙素原(CURB65-A)对 CURB65 评分的增强作用及其对下呼吸道感染预后的预测价值:临床算法的推导。
BMC Infect Dis. 2011 May 3;11:112. doi: 10.1186/1471-2334-11-112.
4
Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.中段肾上腺髓质素作为社区获得性肺炎的一种预后评估工具
Chest. 2009 Sep;136(3):823-831. doi: 10.1378/chest.08-1981. Epub 2009 Apr 10.
5
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.比较B型利钠肽、中段前体A型利钠肽、中段前体肾上腺髓质素和copeptin预测急性失代偿性心力衰竭患者1年死亡率的效果。
J Card Fail. 2007 Feb;13(1):42-9. doi: 10.1016/j.cardfail.2006.09.004.
6
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].前肾上腺髓质素用于预测社区获得性肺炎的严重程度和预后[国际标准随机对照试验编号:ISRCTN04176397]
Crit Care. 2006;10(3):R96. doi: 10.1186/cc4955. Epub 2006 Jun 28.
7
CRB-65 predicts death from community-acquired pneumonia.CRB-65可预测社区获得性肺炎导致的死亡。
J Intern Med. 2006 Jul;260(1):93-101. doi: 10.1111/j.1365-2796.2006.01657.x.
8
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.中段肾上腺髓质素前体作为脓毒症的预后标志物:一项观察性研究。
Crit Care. 2005;9(6):R816-24. doi: 10.1186/cc3885. Epub 2005 Nov 15.
9
Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.根据患者预后研究团队肺炎严重程度指数评估降钙素原水平在社区获得性肺炎中的作用
Chest. 2005 Oct;128(4):2223-9. doi: 10.1378/chest.128.4.2223.
10
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia.感染前全身炎症标志物与肺炎住院风险
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1440-6. doi: 10.1164/rccm.200506-888OC. Epub 2005 Sep 15.